160 related articles for article (PubMed ID: 24858473)
1. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
Ye J; Wu D; Shen J; Wu P; Ni C; Chen J; Zhao J; Zhang T; Wang X; Huang J
Mol Med Rep; 2012 Sep; 6(3):507-12. PubMed ID: 22684815
[TBL] [Abstract][Full Text] [Related]
3. B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells.
Zhi Y; Mou Z; Chen J; He Y; Dong H; Fu X; Wu Y
PLoS One; 2015; 10(8):e0135528. PubMed ID: 26284927
[TBL] [Abstract][Full Text] [Related]
4. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.
Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P
Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848
[TBL] [Abstract][Full Text] [Related]
5. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
[TBL] [Abstract][Full Text] [Related]
7. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
8. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
[TBL] [Abstract][Full Text] [Related]
11. CD24 regulates stemness and the epithelial to mesenchymal transition through modulation of Notch1 mRNA stability by p38MAPK.
Lim J; Lee KM; Shim J; Shin I
Arch Biochem Biophys; 2014 Sep; 558():120-6. PubMed ID: 24977325
[TBL] [Abstract][Full Text] [Related]
12. Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.
Chiu CC; Lee LY; Li YC; Chen YJ; Lu YC; Li YL; Wang HM; Chang JT; Cheng AJ
Cancer Gene Ther; 2013 Nov; 20(11):606-15. PubMed ID: 24201869
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
14. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H
Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153
[TBL] [Abstract][Full Text] [Related]
15. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
16. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
Yoshida GJ; Saya H
Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
[TBL] [Abstract][Full Text] [Related]
17. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
[TBL] [Abstract][Full Text] [Related]
18. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
19. Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).
Ma F; Li H; Wang H; Shi X; Fan Y; Ding X; Lin C; Zhan Q; Qian H; Xu B
Cancer Lett; 2014 Oct; 353(2):153-9. PubMed ID: 25130168
[TBL] [Abstract][Full Text] [Related]
20. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
